Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Primary Antibodies Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Primary Antibodies Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Primary Antibodies

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Primary Antibodies Sales Channel and Distributors Analysis
3.3.1 Primary Antibodies Sales Channel
3.3.2 Primary Antibodies Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in ELISA
3.4.2 Major Buyers in Western Blot
3.5 Primary Antibodies Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Primary Antibodies Type Introduction
4.1.1 Polyclonal
4.1.2 Monoclonal
4.2 Global Primary Antibodies Sales by Type 2016-2021
4.3 Global Primary Antibodies Revenue by Type 2016-2021
4.4 Global Primary Antibodies Price by Type 2016-2021

5 Market Segment: by Application
5.1 Primary Antibodies Type Introduction
5.1.1 ELISA
5.1.2 Western Blot
5.1.3 Immunostaining
5.1.3 Immunohistochemistry
5.1.4 Immunocytochemistry
5.1.5 Other
5.2 Global Primary Antibodies Sales by Application 2016-2021
5.3 Global Primary Antibodies Revenue by Application 2016-2021
5.4 Global Primary Antibodies Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Primary Antibodies Market by Region
6.1.1 Global Primary Antibodies Sales by Regions
6.1.2 Global Primary Antibodies Revenue by Regions
6.2 North America Primary Antibodies Market 2016-2021
6.3 Europe Primary Antibodies Market 2016-2021
6.4 Asia Pacific Primary Antibodies Market 2016-2021
6.5 South America Primary Antibodies Market 2016-2021
6.6 Middle East and Africa Primary Antibodies Market 2016-2021

7 North America
7.1 North America Primary Antibodies Market by Country 2016-2021
7.1.1 North America Primary Antibodies Sales by Country
7.1.2 North America Primary Antibodies Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Primary Antibodies Market by Country 2016-2021
8.1.1 Europe Primary Antibodies Sales by Country
8.1.2 Europe Primary Antibodies Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Primary Antibodies Market by Country 2016-2021
9.1.1 Asia Pacific Primary Antibodies Sales by Country
9.1.2 Asia Pacific Primary Antibodies Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Primary Antibodies Market by Country 2016-2021
10.1.1 South America Primary Antibodies Sales by Country
10.1.2 South America Primary Antibodies Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Primary Antibodies Market by Country 2016-2021
11.1.1 Middle East and Africa Primary Antibodies Sales by Country
11.1.2 Middle East and Africa Primary Antibodies Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Company Information
12.1.2 Thermo Fisher Scientific Primary Antibodies Product Portfolio, Specification and Application
12.1.3 Thermo Fisher Scientific Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Thermo Fisher Scientific Key Development
12.2 Sigma Aldrich Corporation
12.2.1 Sigma Aldrich Corporation Company Information
12.2.2 Sigma Aldrich Corporation Primary Antibodies Product Portfolio, Specification and Application
12.2.3 Sigma Aldrich Corporation Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Sigma Aldrich Corporation Key Development
12.3 Santa Cruz Biotechnology
12.3.1 Santa Cruz Biotechnology Company Information
12.3.2 Santa Cruz Biotechnology Primary Antibodies Product Portfolio, Specification and Application
12.3.3 Santa Cruz Biotechnology Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Santa Cruz Biotechnology Key Development
12.4 R&D Systems
12.4.1 R&D Systems Company Information
12.4.2 R&D Systems Primary Antibodies Product Portfolio, Specification and Application
12.4.3 R&D Systems Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 R&D Systems Key Development
12.5 PeproTech
12.5.1 PeproTech Company Information
12.5.2 PeproTech Primary Antibodies Product Portfolio, Specification and Application
12.5.3 PeproTech Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 PeproTech Key Development
12.6 Novus Biologicals
12.6.1 Novus Biologicals Company Information
12.6.2 Novus Biologicals Primary Antibodies Product Portfolio, Specification and Application
12.6.3 Novus Biologicals Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Novus Biologicals Key Development
12.7 Merk
12.7.1 Merk Company Information
12.7.2 Merk Primary Antibodies Product Portfolio, Specification and Application
12.7.3 Merk Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Novus Biologicals Key Development
12.9 MABTech
12.9.1 MABTech Company Information
12.9.2 MABTech Primary Antibodies Product Portfolio, Specification and Application
12.9.3 MABTech Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 MABTech Key Development
12.8 MBL
12.8.1 MBL Company Information
12.8.2 MBL Primary Antibodies Product Portfolio, Specification and Application
12.8.3 MBL Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 MBL Key Development
12.11 CST
12.11.1 CST Company Information
12.11.2 CST Primary Antibodies Product Portfolio, Specification and Application
12.11.3 CST Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 CST Key Development
12.12 Cayman
12.12.1 Cayman Company Information
12.12.2 Cayman Primary Antibodies Product Portfolio, Specification and Application
12.12.3 Cayman Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Cayman Key Development
12.13 Bio-Rad
12.13.1 Bio-Rad Company Information
12.13.2 Bio-Rad Primary Antibodies Product Portfolio, Specification and Application
12.13.3 Bio-Rad Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 Bio-Rad Key Development
12.14 BD
12.14.1 BD Company Information
12.14.2 BD Primary Antibodies Product Portfolio, Specification and Application
12.14.3 BD Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 BD Key Development
12.15 Abnova
12.15.1 Abnova Company Information
12.15.2 Abnova Primary Antibodies Product Portfolio, Specification and Application
12.15.3 Abnova Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Abnova Key Development
12.17 Abcam

13 Global Primary Antibodies Market Forecast by Region by Type and by Application
13.1 Global Primary Antibodies Sales, Revenue Forecast 2022-2027
13.2 Global Primary Antibodies Forecast by Regions
13.2.1 Global Primary Antibodies Sales Forecast by Region 2022-2027
13.2.2 Global Primary Antibodies Revenue Forecast by Region 2022-2027
13.3 Global Primary Antibodies Forecast by Type
13.3.1 Global Primary Antibodies Sales Forecast by Type 2022-2027
13.3.2 Global Primary Antibodies Revenue Forecast by Type 2022-2027
13.3.3 Global Primary Antibodies Price Forecast by Type 2022-2027
13.4 Global Primary Antibodies Forecast by Application
13.4.1 Global Primary Antibodies Sales Forecast by Application 2022-2027
13.4.2 Global Primary Antibodies Revenue Forecast by Application 2022-2027
13.4.3 Global Primary Antibodies Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Primary Antibodies Production Specifications
Table 2: Drivers in Primary Antibodies Market
Table 3: Restraints Primary Antibodies Market
Table 4: Opportunity in Primary Antibodies Market
Table 5: Comparion of Alternative and Primary Antibodies
Table 6: Primary Antibodies Raw Materials Key Suppliers List
Table 7: Primary Antibodies Distributors List
Table 8: Primary Antibodies Major Buyers in ELISA
Table 9: Primary Antibodies Major Buyers in Western Blot
Table 10: Primary Antibodies Major Buyers in Immunostaining
Table 11: Global Primary Antibodies Sales (K Units) by Type 2016-2021
Table 12: Global Primary Antibodies Sales Market Share by Type 2016-2021
Table 13: Global Primary Antibodies Revenue (Million USD) by Type 2016-2021
Table 14: Global Primary Antibodies Revenue Market Share by Type 2016-2021
Table 15: Global Primary Antibodies Price by Type 2016-2021
Table 16: Global Primary Antibodies Sales (K Units) by Application 2016-2021
Table 17: Global Primary Antibodies Sales Market Share by Application 2016-2021
Table 18: Global Primary Antibodies Revenue (Million USD) by Application 2016-2021
Table 19: Global Primary Antibodies Revenue Market Share by Application 2016-2021
Table 20: Global Primary Antibodies Price by Application 2016-2021
Table 21: Global Primary Antibodies Sales (K Units) by Region 2016-2021
Table 22: Global Primary Antibodies Sales Market Share by Region 2016-2021
Table 23: Global Primary Antibodies Revenue (Million USD) by Region 2016-2021
Table 24: Global Primary Antibodies Revenue Market Share by Region 2016-2021
Table 25: North America Primary Antibodies Sales (K Units) by Country 2016-2021
Table 26: North America Primary Antibodies Sales Market Share by Country 2016-2021
Table 27: North America Primary Antibodies Revenue (Million USD) by Country 2016-2021
Table 28: North America Primary Antibodies Revenue Market Share by Country 2016-2021)
Table 29: Europe Primary Antibodies Sales (K Units) by Country 2016-2021
Table 30: Europe Primary Antibodies Sales Market Share by Country 2016-2021
Table 31: Europe Primary Antibodies Revenue (Million USD) by Country 2016-2021
Table 32: Europe Primary Antibodies Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Primary Antibodies Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Primary Antibodies Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Primary Antibodies Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Primary Antibodies Revenue Market Share by Country 2016-2021)
Table 37: South America Primary Antibodies Sales (K Units) by Country 2016-2021
Table 38: South America Primary Antibodies Sales Market Share by Country 2016-2021
Table 39: South America Primary Antibodies Revenue (Million USD) by Country 2016-2021
Table 40: South America Primary Antibodies Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Primary Antibodies Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Primary Antibodies Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Primary Antibodies Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Primary Antibodies Revenue Market Share by Country 2016-2021)
Table 45 Thermo Fisher Scientific Company Information
Table 46 Thermo Fisher Scientific Primary Antibodies Product Portfolio, Specification and Application
Table 47 Thermo Fisher Scientific Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Sigma Aldrich Corporation Company Information
Table 49 Sigma Aldrich Corporation Primary Antibodies Product Portfolio, Specification and Application
Table 50 Sigma Aldrich Corporation Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Santa Cruz Biotechnology Company Information
Table 52 Santa Cruz Biotechnology Primary Antibodies Product Portfolio, Specification and Application
Table 53 Santa Cruz Biotechnology Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 R&D Systems Company Information
Table 55 R&D Systems Primary Antibodies Product Portfolio, Specification and Application
Table 56 R&D Systems Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 PeproTech Company Information
Table 58 PeproTech Primary Antibodies Product Portfolio, Specification and Application
Table 59 PeproTech Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Novus Biologicals Company Information
Table 61 Novus Biologicals Primary Antibodies Product Portfolio, Specification and Application
Table 62 Novus Biologicals Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Merk Company Information
Table 64 Merk Primary Antibodies Product Portfolio, Specification and Application
Table 65 Merk Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 MBL Company Information
Table 67 MBL Primary Antibodies Product Portfolio, Specification and Application
Table 68 MBL Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 MABTech Company Information
Table 70 MABTech Primary Antibodies Product Portfolio, Specification and Application
Table 71 MABTech Primary Antibodies Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Primary Antibodies Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Primary Antibodies Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Primary Antibodies Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Primary Antibodies Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Primary Antibodies Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Primary Antibodies Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Primary Antibodies Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Primary Antibodies Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Primary Antibodies Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Primary Antibodies Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Primary Antibodies Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Primary Antibodies Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Primary Antibodies Picture
Figure 2: Global Primary Antibodies Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Primary Antibodies Supply Chain Analysis
Figure 5: Primary Antibodies Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Polyclonal
Figure 7: Product Picture of Monoclonal
Figure 8: Global Primary Antibodies Sales Market Share by Type, 2020
Figure 9: Global Primary Antibodies Revenue Market Share by Type, 2020
Figure 10: Primary Antibodies in ELISA
Figure 11: Global Primary Antibodies Market: ELISA 2016-2021
Figure 12: Primary Antibodies in Western Blot
Figure 13: Global Primary Antibodies Market: Western Blot 2016-2021
Figure 14: Global Primary Antibodies Sales Market Share by Application, 2020
Figure 15: Global Primary Antibodies Revenue Market Share by Application, 2020
Figure 16: Global Primary Antibodies Sales Market Share by Region 2016-2021
Figure 17: Global Primary Antibodies Revenue Market Share by Region 2016-2021
Figure 18: North America Primary Antibodies Sales (K Units) Status 2016-2021
Figure 19: North America Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 20: Europe Primary Antibodies Sales (K Units) Status 2016-2021
Figure 21: Europe Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Primary Antibodies Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 24: South America Primary Antibodies Sales (K Units) Status 2016-2021
Figure 25: South America Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Primary Antibodies Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 28: North America Primary Antibodies Sales Market Share by Country, 2020
Figure 29: North America Primary Antibodies Revenue Market Share by Country, 2020
Figure 30: United States Primary Antibodies Sales (K Units) Status 2016-2021
Figure 31: United States Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 32: Canada Primary Antibodies Sales (K Units) Status 2016-2021
Figure 33: Canada Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Primary Antibodies Sales (K Units) Status 2016-2021
Figure 35: Mexico Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 36: Europe Primary Antibodies Sales Market Share by Country, 2020
Figure 37: Europe Primary Antibodies Revenue Market Share by Country, 2020
Figure 38: Germany Primary Antibodies Sales (K Units) Status 2016-2021
Figure 39: Germany Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 40: France Primary Antibodies Sales (K Units) Status 2016-2021
Figure 41: France Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 42: UK Primary Antibodies Sales (K Units) Status 2016-2021
Figure 43: UK Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 44: Italy Primary Antibodies Sales (K Units) Status 2016-2021
Figure 45: Italy Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 46: Russia Primary Antibodies Sales (K Units) Status 2016-2021
Figure 46: Russia Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 47: Spain Primary Antibodies Sales (K Units) Status 2016-2021
Figure 48: Spain Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Primary Antibodies Sales Market Share by Country, 2020
Figure 50: Asia Pacific Primary Antibodies Revenue Market Share by Country, 2020
Figure 51: China Primary Antibodies Sales (K Units) Status 2016-2021
Figure 52: China Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 53: Japan Primary Antibodies Sales (K Units) Status 2016-2021
Figure 54: Japan Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 55: Korea Primary Antibodies Sales (K Units) Status 2016-2021
Figure 56: Korea Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Primary Antibodies Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 59: India Primary Antibodies Sales (K Units) Status 2016-2021
Figure 60: India Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 61: Australia Primary Antibodies Sales (K Units) Status 2016-2021
Figure 62: Australia Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 63: South America Primary Antibodies Sales Market Share by Country, 2020
Figure 64: South America Primary Antibodies Revenue Market Share by Country, 2020
Figure 65: Brazil Primary Antibodies Sales (K Units) Status 2016-2021
Figure 66: Brazil Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Primary Antibodies Sales (K Units) Status 2016-2021
Figure 68: Argentina Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Primary Antibodies Sales (K Units) Status 2016-2021
Figure 70: Colombia Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Primary Antibodies Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Primary Antibodies Revenue Market Share by Country, 2020
Figure 73: Turkey Primary Antibodies Sales (K Units) Status 2016-2021
Figure 74: Turkey Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Primary Antibodies Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Primary Antibodies Sales (K Units) Status 2016-2021
Figure 78: South Africa Primary Antibodies Revenue (Million USD) Status 2016-2021
Figure 79: Thermo Fisher Scientific Primary Antibodies Revenue Market Share Globally (2019-2021)
Figure 80: Sigma Aldrich Corporation Primary Antibodies Revenue Market Share Globally (2019-2021)
Figure 81: Santa Cruz Biotechnology Primary Antibodies Revenue Market Share Globally (2019-2021)
Figure 82: R&D Systems Primary Antibodies Revenue Market Share Globally (2019-2021)
Figure 83: PeproTech Primary Antibodies Revenue Market Share Globally (2019-2021)
Figure 84: Novus Biologicals Primary Antibodies Revenue Market Share Globally (2019-2021)
Figure 85: Merk Primary Antibodies Revenue Market Share Globally (2019-2021)
Figure 86: MBL Primary Antibodies Revenue Market Share Globally (2019-2021)
Figure 87: MABTech Primary Antibodies Revenue Market Share Globally (2019-2021)
Figure 88: KPL Primary Antibodies Revenue Market Share Globally (2019-2021)
Figure 89: Global Primary Antibodies Sales (K Units) Forecast (2022-2027)
Figure 90: Global Primary Antibodies Sales (K Units) Forecast (2022-2027)